How is immune thrombocytopenia (ITP) diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Diagnose ITP

ITP is fundamentally a diagnosis of exclusion, established when isolated thrombocytopenia (platelet count <100 × 10⁹/L) is confirmed on peripheral blood smear without other identifiable causes, based on targeted history, physical examination, and selective laboratory testing. 1

Core Diagnostic Criteria

ITP requires:

  • Platelet count <100 × 10⁹/L (not <150 × 10⁹/L as in other conditions)
  • Isolated thrombocytopenia - all other blood counts must be normal
  • No alternative explanation for the low platelet count

Essential Initial Workup

Mandatory Basic Evaluation 1

Every patient requires:

  • Complete blood count with reticulocyte count - confirms isolated thrombocytopenia; anemia should only be proportional to bleeding

  • Peripheral blood smear review by qualified hematologist/pathologist - this is paramount and non-negotiable; excludes schistocytes (TTP), giant/small platelets (inherited thrombocytopenias), leukocyte inclusions (MYH9 disease), and EDTA-induced pseudothrombocytopenia

  • Detailed patient history focusing on:

    • Drug exposures (heparin, quinidine/quinine, sulfonamides, alcohol)
    • HIV/HCV risk factors or known infection
    • Autoimmune disease symptoms (arthralgias, rash, alopecia)
    • Recent infections or vaccinations
    • Family history of thrombocytopenia or bleeding
    • Bleeding with prior surgeries/pregnancies
  • Physical examination specifically assessing:

    • Bleeding manifestations only (petechiae, purpura, mucosal bleeding)
    • Absence of splenomegaly (moderate/massive splenomegaly excludes ITP; <3% have mild splenomegaly) 2
    • Absence of lymphadenopathy, hepatomegaly, fever, weight loss (suggests alternative diagnosis)

Selective Additional Testing 1

Tests of potential utility based on clinical context:

  • HIV and HCV serology - recommended for all adults regardless of geographic location 1
  • Direct antiglobulin test - if hemolytic anemia suspected
  • Quantitative immunoglobulin levels - particularly in children with persistent/chronic ITP
  • Pregnancy test - all women of childbearing potential
  • H. pylori testing (urea breath test or stool antigen preferred over serology) - consider in adults where treatment would be pursued 1
  • Antiphospholipid antibodies - if thrombosis history or other autoimmune features
  • Thyroid function and antithyroid antibodies - if clinical suspicion

Bone Marrow Examination

When NOT needed (strong recommendations): 3

  • Children and adolescents with typical ITP features (Grade 1B)
  • Children who fail IVIg therapy (Grade 1B)
  • Before corticosteroid initiation in typical cases (Grade 2C)

When to consider: 1

  • Age >60 years
  • Systemic symptoms or abnormal signs
  • Abnormal blood counts beyond isolated thrombocytopenia
  • Before splenectomy in some cases
  • When performed: obtain both aspirate and biopsy; consider flow cytometry and cytogenetics

Tests That Are NOT Helpful

Do not order: 1, 2

  • Platelet-associated IgG (PaIgG) - inappropriate and unnecessary
  • Thrombopoietin (TPO) levels - unproven benefit
  • Reticulated platelets - unproven benefit
  • Platelet survival studies - unnecessary
  • Bleeding time - unproven benefit
  • Serum complement - unnecessary
  • Antinuclear antibodies - not necessary in children/adolescents 3

Glycoprotein-specific platelet antibodies (MAIPA method): High specificity but only ~50% sensitivity; supportive when positive but does not exclude ITP when negative 4, 5, 6

Critical Pitfalls to Avoid

  1. Pseudothrombocytopenia: Always confirm on peripheral smear; EDTA-dependent platelet clumping occurs in ~0.1% of adults 2, 1

  2. Missing secondary causes:

    • Drug-induced (especially heparin, quinidine, sulfonamides)
    • HIV/HCV infection (may precede other symptoms by years) 1
    • Autoimmune diseases (SLE, antiphospholipid syndrome)
    • Lymphoproliferative disorders (CLL can present as ITP)
  3. Splenomegaly presence: Moderate or massive splenomegaly essentially excludes primary ITP 1

  4. Abnormal blood counts: Any abnormality beyond isolated thrombocytopenia (and proportional anemia from bleeding) requires alternative explanation 1

  5. Atypical smear findings: Schistocytes, abnormal white cells, or platelet size abnormalities mandate further investigation 1

Diagnostic Algorithm Summary

Step 1: Confirm true thrombocytopenia on peripheral smear (exclude pseudothrombocytopenia)

Step 2: Verify isolated thrombocytopenia with normal CBC otherwise (proportional anemia from bleeding acceptable)

Step 3: Expert peripheral smear review - must show no alternative findings

Step 4: Targeted history and physical excluding secondary causes and alternative diagnoses

Step 5: Selective testing: HIV/HCV in adults, pregnancy test in women, consider H. pylori

Step 6: Bone marrow only if: age >60, atypical features, systemic symptoms, or abnormal counts

If all above consistent with ITP and no alternative diagnosis identified → Diagnosis established

The diagnosis remains clinical and based on exclusion; no single confirmatory test exists. Response to ITP-specific therapy (IVIg, anti-D, corticosteroids) supports but does not confirm the diagnosis, as secondary ITP may also respond 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.